Arthritis Research & Therapy

official impact factor 4.36

Open Access

The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes

Gaby Palmer, Danielle Burger, Françoise Mezin, David Magne, Cem Gabay, Jean-Michel Dayer and Pierre-André Guerne*

Arthritis Res Ther 2004, 6:R181-R189 doi:10.1186/ar1157

Accesses  

  • Last 30 days: 41 accesses
  • Last 365 days: 549 accesses
  • All time: 3959 accesses